These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10993598

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

  • 11. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May 15; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 12. The role for growth hormone in linking arthritis, osteoporosis, and body composition.
    Tauchmanova L, Di Somma C, Rusciano A, Lombardi G, Colao A.
    J Endocrinol Invest; 2007 May 15; 30(6 Suppl):35-41. PubMed ID: 17721072
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study.
    Appelman-Dijkstra NM, Claessen KM, Hamdy NA, Pereira AM, Biermasz NR.
    Clin Endocrinol (Oxf); 2014 Nov 15; 81(5):727-35. PubMed ID: 24816144
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone and bone.
    Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC.
    Endocr Rev; 1998 Feb 15; 19(1):55-79. PubMed ID: 9494780
    [Abstract] [Full Text] [Related]

  • 16. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
    Aimaretti G, Corneli G, Rovere S, Croce CG, Ghigo E, Procopio M.
    J Endocrinol Invest; 2005 Feb 15; 28(10 Suppl):28-32. PubMed ID: 16550719
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan 15; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
    Sneppen SB, Hoeck HC, Kollerup G, Sørensen OH, Laurberg P, Feldt-Rasmussen U.
    Eur J Endocrinol; 2002 Feb 15; 146(2):187-95. PubMed ID: 11834427
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.